about
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune diseaseCCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance.Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient miceXerophthalmia of Sjogren's Syndrome Diagnosed with Anti-Salivary Gland Protein 1 Antibodies.Characterization of Angiogenesis and Lymphangiogenesis in Human Minor Salivary Glands with Sjögren's Syndrome.Lamivudine is not effective in primary Sjögren's syndrome.Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndromeCritical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.Clinical and pathological roles of Ro/SSA autoantibody system.Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumThe rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphomaAromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease.Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome.Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.Regulation of the P2X7 receptor permeability to large molecules by extracellular Cl- and Na+.CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia.Evaluation of Swallowing Functions in Patients with Sjögren's Syndrome.Anti-SSA antibodies are present in immunoglobulin preparations.Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset.Anti-ribonucleoproteins autoantibodies in patients with systemic autoimmune diseases. Relation with cutaneous photosensitivity.
P2860
Q24657833-6C635F88-1100-4C97-9F36-A02A935A33EFQ27308795-4C794D89-4C7F-4800-B848-591D800737F3Q30414128-64147E3C-785F-4BAA-B242-FD670B59A1B4Q33929820-3A770F26-EF18-4CDC-8014-E14E23E39596Q35538642-798BCC60-8462-4B90-B7B0-05CB93FE413FQ35556009-EE82830F-5AC7-4694-B99D-053A8F47BB19Q35769293-6AEE0E4D-08F2-467A-9950-8AB50DD33FF3Q36204121-0F0E4544-E329-4BB4-8855-7E2B4DD38BA3Q36469094-5A584025-9AA4-4C2C-9209-A2677D7427FDQ36528740-0F6DABF7-DC8E-416B-B788-59A0E7FD07E9Q37422510-41D92F69-3405-4CDF-9F6E-66C0B0CB0F9DQ37494115-51CBF76B-F985-40D8-88F0-6192C5E7161AQ38813104-0A611C5E-9D1B-4BB2-B8E9-E944AC62345CQ38956613-1C781D93-8DA1-4421-BE7E-B1021BBCA6C9Q40370028-35F30039-2416-4427-9DB2-4149109C75FEQ40415801-8DA72C72-F550-4657-85A1-98A7A3814084Q46351256-BF1F35ED-773F-4B4B-847C-5BB1C66CC8A4Q48035705-3987D78A-8F5C-4719-8950-69F98BF1BB9EQ48253282-016E5BF9-4F4F-4499-9DB4-ACF74FF3029CQ50492763-90B1A48D-A17F-4CD2-B0ED-7315F41CC294Q53067971-14C933FD-3D1D-402C-A83F-7D2EC8BDCD57
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenesis of Sjögren's syndrome.
@ast
Pathogenesis of Sjögren's syndrome.
@en
Pathogenesis of Sjögren's syndrome.
@nl
type
label
Pathogenesis of Sjögren's syndrome.
@ast
Pathogenesis of Sjögren's syndrome.
@en
Pathogenesis of Sjögren's syndrome.
@nl
prefLabel
Pathogenesis of Sjögren's syndrome.
@ast
Pathogenesis of Sjögren's syndrome.
@en
Pathogenesis of Sjögren's syndrome.
@nl
P1433
P1476
Pathogenesis of Sjögren's syndrome.
@en
P2093
Kazuhiko Yamamoto
P356
10.1016/S1568-9972(02)00121-0
P577
2003-01-01T00:00:00Z